3505 results for «4»

Filter By

3505 results

EuroPCR 2025 Closing Ceremony

23 May 2025 – From EuroPCR 2025

Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.

EuroPCR 2025 Closing Ceremony

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

21 May 2025 – From EuroPCR 2025

Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

Andreas Grüntzig Ethica Award

22 May 2025 – From EuroPCR 2025

Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.

Andreas Grüntzig Ethica Award

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

22 May 2025 – From EuroPCR 2025

Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.

EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome

Refractory heart failure: combining oral therapy and device is key

21 May 2025 – From EuroPCR 2025

Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.

Refractory heart failure: combining oral therapy and device is key
Didn’t find what you were looking for?